Sibylle Moltzen Lenz
Network origin in Sibylle Moltzen Lenz first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 8 | |
| Public Company | Pharmaceuticals: Major | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Sibylle Moltzen Lenz via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| BIOTAGE AB | Medical Specialties | Founder Sales & Marketing | |
| BIOGAIA AB | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Founder Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| CELLAVISION AB | Medical Specialties | Founder Director/Board Member | |
| CAMURUS AB | Pharmaceuticals: Major | Director/Board Member | |
| INVISIO AB | Telecommunications Equipment | Director/Board Member | |
| University of Lund | College/University | Doctorate Degree Masters Business Admin Graduate Degree Graduate Degree Graduate Degree Corporate Officer/Principal Doctorate Degree | |
Atlas Antibodies AB
 Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | Biotechnology | Founder Director/Board Member | |
| NIMUTAN AB (PUBL) | Household/Personal Care | Director/Board Member | |
| University of Gothenburg | College/University | Corporate Officer/Principal | |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Investment Managers | Private Equity Investor | |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| Handelshögskolan i Göteborg | College/University | Masters Business Admin | |
| EQL PHARMA AB | Pharmaceuticals: Generic | Founder Director/Board Member | |
Sahlgrenska Universitetssjukhuset
 Sahlgrenska Universitetssjukhuset Hospital/Nursing ManagementHealth Services Sahlgrenska Universitetssjukhuset engages in the provision of basic and emergency medical care. It offers specialized care, pediatrics, transplant activity, treatment of cardiovascular diseases, immunology, and vaccine research. Its hospital provides an infrastructure necessary for teaching and research. The company was founded on January 1, 1997 and is based in Gothenburg, Sweden. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Spiber Technologies AB | Director/Board Member | ||
Laccure AB
 Laccure AB Pharmaceuticals: GenericHealth Technology Laccure AB develops products for the treatment and prevention of bacterial vaginosis. It is a pharmaceutical company that offers non-prescription vaginal tablet for women. The firm's product is based on a proprietary substance that releases lactic acid over an extended period of time to decrease elevated vaginal potential of hydrogen. It engages in research, development, training, marketing, and sales in the field of skin care and hygiene activities. The company was founded by Olov Arvid Sterner in 2007 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Generic | Founder | |
| Scibase Intressenter AB | Director/Board Member | ||
Fiomi Diagnostics AB
 Fiomi Diagnostics AB Medical SpecialtiesHealth Technology Part of MiCo IVD Holdings, LLC, Fiomi Diagnostics AB is a Swedish company that develops, manufactures, and markets diagnostic test kits. The company is based in Uppsala, Sweden. Fiomi Diagnostics was acquired by Trinity Biotech Plc on March 01, 2012 for $13.12 million. | Medical Specialties | Director/Board Member | |
Eirus Medical AB
 Eirus Medical AB Miscellaneous Commercial ServicesCommercial Services Part of Getinge AB, Eirus Medical AB is a Swedish company that provides medical technology development services. The company is based in Solna, Sweden. Eirus Medical was acquired by Getinge AB from Dipylon Medical AB on June 30, 2012 for $0.72 million. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Atlas Therapeutics AB
 Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Ginolis AB
 Ginolis AB Miscellaneous ManufacturingProducer Manufacturing Ginolis AB develops components in polymer by first producing the parts in original through different methods for sculpting silicon and glass wafers. These originals are transferred to molds in which the final components are manufactured through time-effective and thus economical favorable polymer replication processes. The polymers themselves, compared with silicon micromechanics, could also add material property advantages with the vast variety of materials available. They can with this platform serve many different fields all with the same need of precision and complexity. Ginolis AB has the skill and experience to integrate different functions onto the very same chip in order to achieve functions that, if they are at all possible to manufacture with traditional technique, needs several parts assembled to mechanical systems with higher cost for the parts as a consequence. These functions include nano- and microfludic channels, surface chemistry, electrical wave guides and connectors, refractive and diffractive micro-optics. | Miscellaneous Manufacturing | Director/Board Member | |
Karo Pharma Med AB
 Karo Pharma Med AB Pharmaceuticals: MajorHealth Technology Karo Pharma Med AB develops, manufactures, and markets new medical technology products and drugs for infectious diseases. It also engages I research and development. The company was founded by Nils Krister Tano in 2008 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Scibase AB | Director/Board Member | ||
| INTELLEGO TECHNOLOGIES AB | Electronic Components | Director/Board Member Chairman | |
| P/S Sunstone Biomedicinsk Venture III | Investment Managers | Director/Board Member | |
| Sunstone LSV Partners & Co. Holding III ApS | Corporate Officer/Principal | ||
| Sunstone LSV Partners Holding III ApS | Corporate Officer/Principal | ||
| Sunstone LSV & Co. Special Limited Partner III Holding ApS | Corporate Officer/Principal | ||
| Sunstone LSV Invest III ApS | Corporate Officer/Principal | ||
| Medical Manual Europé AB | Chairman | ||
| Intorp Säteri AB | Director/Board Member | ||
| Fastighetsaktiebolaget Bogesund | Director/Board Member | ||
| Jollingham ApS | Corporate Officer/Principal | ||
| Ximi 2015 Holding AB | Director/Board Member | ||
| Lindberg Life-Science AB | Chief Executive Officer | ||
| Bostadsrattsforeningen Astraea | Director/Board Member | ||
| Kihlstroms Frimarkshandel AB | Director/Board Member | ||
| Bostadsrattsforeningen Johannes Mindre | Director/Board Member | ||
| Oncopeptides Incentive AB | Corporate Officer/Principal | ||
| ASCELIA PHARMA AB | Pharmaceuticals: Major | Chairman | |
| CMC SPV of 3 April 2017 AB | Director/Board Member Director/Board Member | ||
| Ascelia Incentive AB | Chairman | ||
Oncopeptides, Inc.
 Oncopeptides, Inc. Medical/Nursing ServicesHealth Services Part of Oncopeptides AB, Oncopeptides, Inc. is a company committed to developing therapies for difficult-to-treat hematological diseases. The company is based in Waltham, MA. Oncopeptides strives to bring hope to patients through science and innovation, and is dedicated to bringing forward new and meaningful treatment options. The company is inspired by the perseverance of patients, caregivers, and healthcare providers in their fight against cancer. Oncopeptides' focus is on the development of therapies that can make a difference in the lives of those affected by hematological diseases. | Medical/Nursing Services | Director/Board Member |
Statistics
International
| Sweden | 40 |
| Denmark | 8 |
| United States | 4 |
| Brazil | 2 |
Sectoral
| Health Technology | 16 |
| Finance | 4 |
| Commercial Services | 4 |
| Consumer Services | 4 |
| Electronic Technology | 3 |
Operational
| Director/Board Member | 165 |
| Corporate Officer/Principal | 44 |
| Chairman | 32 |
| Independent Dir/Board Member | 25 |
| Chief Executive Officer | 21 |
Most connected contacts
- Stock Market
- Insiders
- Sibylle Moltzen Lenz
- Company connections
